CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will present at the Alliance for Regenerative Medicine’s 3rd Annual Regen Med Investor Day on Wednesday, March 25, 2015 at 4:20 p.m. ET at the Metropolitan Club in New York City. bluebird bio will also participate in a panel titled, “Adoptive T-Cell Therapies: Considering Key Upcoming Clinical & Commercial Milestones” at 3:10 p.m. ET.
Help employers find you! Check out all the jobs and post your resume.
